Literature DB >> 16990718

Variants of human papillomavirus types 16 and 18: histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear.

Silvia Helena Rabelo-Santos1, Luísa Lina Villa, Sophie Françoise Derchain, Silvaneide Ferreira, Luis Otávio Zanatta Sarian, Liliana Aparecida Lucci Angelo-Andrade, Maria Cristina do Amaral Westin, Luiz Carlos Zeferino.   

Abstract

Human papillomavirus (HPV) genotypes cannot fully explain the histological diagnosis of women with glandular abnormalities detected by cervical smear. Thus, this study was designed to analyze the distribution of HPV-16 and HPV-18 variants in women referred because of atypical glandular cells and adenocarcinoma in situ in their cervical smears and its association with histological results. Twenty-four women with HPV-16 and 6 with HPV-18, selected from 160 women with cervical smears suggestive of glandular abnormalities, were included. Histological results showed cervicitis (1 case), squamous neoplasia (18 cases), glandular neoplasia (7 cases), and glandular neoplasia associated with a squamous component (4 cases). Among the 24 cases presenting HPV-16, the European variant was detected in 15 (62%) and the Asian American in 9 (38%). Among the 15 cases associated with the European variant, 14 (93%) presented squamous neoplasia and 1 (7%) invasive adenocarcinoma. Asian-American HPV-16 variants were significantly associated with histological diagnosis of glandular neoplasia alone (odds ratio, 9.3 [1.4-60.2]) or associated with squamous neoplasia (odds ratio, 18.7 [1.5-232.3]). Adenocarcinomas were detected in 4 of 6 HPV-18-positive cases, being 2 cases had the European variant, 1 had the Asian Amerindian variant, and 1 had the African variant. The association of HPV-16 with squamous or glandular neoplasia is explained by its variants. In this study, squamous neoplasia was related to the European variant of HPV-16, whereas glandular neoplasia was related to the Asian-American variant. Glandular neoplasia is associated with HPV-18, but the results of our analysis of its variants were inconclusive.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990718     DOI: 10.1097/01.pgp.0000215302.17029.0c

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

1.  Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.

Authors:  K A Lang Kuhs; D L Faden; L Chen; D K Smith; M Pinheiro; C B Wood; S Davis; M Yeager; J F Boland; M Cullen; M Steinberg; S Bass; X Wang; P Liu; M Mehrad; T Tucker; J S Lewis; R L Ferris; L Mirabello
Journal:  Ann Oncol       Date:  2022-03-16       Impact factor: 51.769

2.  HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women.

Authors:  Lisa Mirabello; Meredith Yeager; Michael Cullen; Joseph F Boland; Zigui Chen; Nicolas Wentzensen; Xijun Zhang; Kai Yu; Qi Yang; Jason Mitchell; David Roberson; Sara Bass; Yanzi Xiao; Laurie Burdett; Tina Raine-Bennett; Thomas Lorey; Philip E Castle; Robert D Burk; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2016-04-29       Impact factor: 13.506

3.  Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions.

Authors:  Luciana Bueno Freitas; Zigui Chen; Elaine Freire Muqui; Neide Aparecida Tosato Boldrini; Angélica Espinosa Miranda; Liliana Cruz Spano; Robert D Burk
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

4.  The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.

Authors:  Lisa Mirabello; Megan A Clarke; Chase W Nelson; Michael Dean; Nicolas Wentzensen; Meredith Yeager; Michael Cullen; Joseph F Boland; Mark Schiffman; Robert D Burk
Journal:  Viruses       Date:  2018-02-13       Impact factor: 5.048

5.  Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.

Authors:  Gary M Clifford; Vanessa Tenet; Damien Georges; Laia Alemany; Miquel Angel Pavón; Zigui Chen; Meredith Yeager; Michael Cullen; Joseph F Boland; Sara Bass; Mia Steinberg; Tina Raine-Bennett; Thomas Lorey; Nicolas Wentzensen; Joan Walker; Rosemary Zuna; Mark Schiffman; Lisa Mirabello
Journal:  Papillomavirus Res       Date:  2019-02-06

6.  Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer.

Authors:  Silvia Helena Rabelo-Santos; Lara Termini; Enrique Boccardo; Sophie Derchain; Adhemar Longatto-Filho; Maria Antonieta Andreoli; Maria Cecília Costa; Rafaella Almeida Lima Nunes; Liliana Aparecida Lucci Ângelo-Andrade; Luisa Lina Villa; Luiz Carlos Zeferino
Journal:  Oncotarget       Date:  2018-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.